Wes Pegden Profile picture
Sep 20, 2020 12 tweets 4 min read Read on X
A quick note on this thread by @joel_c_miller before bedtime.

Joel is summarizing a nice argument coming from random graphs to suggest that increasing transmission rates among low-risk groups cannot be good, unless accompanied by other decreases. 🧵 1/9

This argument is valid if comparing two scenarios with constant transmissions. It is not valid if we expect (as I think we do!) that transmission patterns will eventually increase.

In particular, it is worth noting, that... 2/9
even in the simplest single-population models with time-varying transmission rates, epidemic sizes (and thus mortality) can be decreased by increases in transmission.[🤯]

Time dynamics make coupled systems complex, and intuitive reasoning about the effects of changes is tricky.
In particular, Joel suggests that increasing low-risk transmission cannot help if we do not correspondingly manage to decrease transmission to or within high-risk groups. But in our paper with @ChikinaLab, counterexamples to this principle can be found.

For example, 4/9
the only change between transmission patterns in our Figures 2B & 4B are that in the latter, transmission levels are pointwise higher for <40 year olds than in the former. Mortality drops by more than 70%.

Why isn't this precluded by Joel's argument? 5/9
journals.plos.org/plosone/articl…
Joel suggests that to improve things, these strategies would have to enact corresponding decreases among high-risk groups. But we don't do that: these transmission levels are the same in these two figures in our paper.

On the other hand, because transmission is... 6/9
... not constant (in particular, we assume that eventually, it will increase), changing *when* low-risk people become infected can significantly reduce transmission to older people.

This is why, in this tweet, it is not true that... 7/9

"the number of H individuals per L infection are unchanged." (Also, because of the 🤯 above, the last line can also be false.)

The analysis we present in our paper is relatively simple and based on mainstream formulations of simple epidemic models.

Some references for 🤯:
8/9
We gave some simple counterexamples to monotonocity principles (for homogeneous models!) in our manuscript here:



Nonmonotonicity was previously addressed by Bacaer and Gomes:

link.springer.com/article/10.100…

These both show the importance of time dynamics.
I did not notice before posting that 21 tweets in, Joel acknowledges this caveat.

I hope it is clear this is the core disagreement from those who ignore age-targeting:

10/9

Are we sure we can delay any transmission increases until a new game-changing development?

I do not think most decision-makers realize this is the assumption required to believe their policies are not dangerous.

And we have already seen this assumption fail. 11/9
Let me point out that Joel thinks I am being unfair here and that actually he clearly only intended to talk about the case where transmission rates are constant.

Let's all take part in the contest I propose in the tweet after this one: 12/9

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Wes Pegden

Wes Pegden Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @WesPegden

Sep 15, 2022
Our statistical re-analysis of the Bangladesh mask trial data with @ChikinaLab and @beenwrekt has been published in Trials (@MedicalEvidence).

1/4

trialsjournal.biomedcentral.com/articles/10.11…
The Bangladesh trial was a big lift and to date the only cluster randomized trial of masks to generate any publicly available data. Another pre-registered trial in Bangladesh by the same authors was suspended, and a pre-registered trial in Guinnea-Bissau never reported.
2/4
This unfortunately leaves us reading the tea leaves in this one completed study.

This paper is our read of the tea leaves.
3/4
Read 4 tweets
May 16, 2022
The most pressing questions about the COVID pandemic don't come in the form "can X happen?".

I was surprised at how little quantitative information this article contains, especially when we actually do have high quality data on reinfections.

1/
The ONS survey tracks reinfections through surveillance testing among its random sample of participants. Even though the recent Omicron waves, the observed reinfection rate has been 1 per thousand or so days.

2/

ons.gov.uk/peoplepopulati… Image
These rates are no guarantee of the future, but science journalism should present the best data have, rather than relying on anecdotes.

In lieu of data like this, the article instead leans heavily on the feelings shared by expert commentators (every one of whom is on Twitter).3/
Read 8 tweets
Feb 4, 2022
As a growing number of people criticize continued restrictions on children and young people, the responses hurdled back are not defenses of still concealing faces from weeks-old infants or making 6 year olds eat lunch silently and wear masks while they learn to read, but this:
1/
Some are pure-style assertions that "these people are bad, dying is bad, COVID is not over, I am on the other team".

Others have gone full-blown connect-the-dots conspiracy, trying to uncover the mystery of why people care about young people's day-to-day experiences.
2/6
What I have not seen from many in the past months is a full-throated defense of the specific policies that children (and babies) are being been subjected to.

Who's for it!? Anyone? Or are we all against it, but sure that some of us are bad people against it in the wrong way?
3/6
Read 9 tweets
Feb 3, 2022
The pre-registration for the next phase of the Bangladesh mask trial (@Jabaluck etc) has been posted.

The good: it will probe a bias-resistant endpoint that should be much less dependent on subjective survey responses.

Two important criticisms follow:1/8
clinicaltrials.gov/ct2/show/NCT05…
1) The new phase of the trial still doesn't have any placebo intervention (like, say, education only).

One of the things our re-analysis of their previous study showed is that staff and participants were subject to big differences in study behavior.
2/8
arxiv.org/abs/2112.01296
The study found much larger effects on physical distancing than on COVID; in general, it seems likely that intervention villages are considerably more "COVID aware".

If we really care whether masks are actually helping, comparing, masks+education to education would make sense!
/
Read 8 tweets
Feb 1, 2022
In the pandemic's 1st year, failing to focus resources and attention on the oldest+most vulnerable in society meant young people faced excessive restrictions that were senseless from a public health perspective.

In the 2nd year, it meant inordinate levels of preventable death.
Commentators on here spend a lot of time talking about low-stakes controversial policies whose only merit is that they scratch a political itch.

Meanwhile the actual failure to vax and boost the oldest (and even LTC) populations goes largely unmentioned, except by "contrarians".
From the CDC:
cdc.gov/nhsn/covid19/l…

Vaccination rate among LTC residents: 87%
Booster rate *among vaccinated* LTC residents: leveling off at 67%

42% of LTC residents have fewer than 3 doses.

Look at the coverage maps.

A lot of "COVID-focused" states have <75% booster rates. ImageImageImageImage
Read 7 tweets
Feb 1, 2022
This article is remarkable.

As it discusses, the trials for a 2 dose vaccine in 6 mos-5 year olds failed. But now the FDA seems keen to just grant emergency use authorization anyways, while data from trials of a 3-dose regimen are still a ways out.

1/

washingtonpost.com/nation/2022/01…
The next thing to watch for will be mandates for under 5's, for a vaccine under emergency use authorization in a low risk population whose only trial failed.

Meanwhile the US has some of the lowest vaccination and booster rates among the most vulnerable populations.

2/
I think it's a mistake to miss the connection between these.

We have confused people about risk, needlessly politicized our response, and tried to distract from crucial policy failures among high risk groups with policies aimed at children and young people.

3/
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(